Japan Community Health care Organization Kyushu Hospital
Kitakyushu, Japan
General hospital in Kitakyushu
1 Chome-8-番１号 Kishinoura, Yahatanishi Ward, Kitakyushu, Fukuoka 806-8501
About Japan Community Health care Organization Kyushu Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
4
Bayer
3
Janssen Research & Development, LLC
3
Chugai Pharmaceutical
2
Arena Pharmaceuticals
1
Celgene
1
Five Prime Therapeutics, Inc.
1
Pfizer
1
Clinical Trials at Japan Community Health care Organization Kyushu Hospital
During the past decade, Japan Community Health care Organization Kyushu Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 8 clinical trials were completed, i.e. on
average, 53.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 7 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
2014-11-27
2018-08-14
Completed
5,390
Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)
2016-01-06
2030-04-22
Active, not recruiting
551
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
2017-03-06
2020-05-28
Completed
3,730
A Study of Molidustat for Treatment of Renal Anemia in Peritoneal Dialysis Subjects
2018-02-22
2019-07-29
Completed
51
A Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL)
2018-08-15
2021-07-08
Completed
1,026
A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer
2018-09-14
2022-05-13
Completed
155
A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery
2019-06-17
2021-04-06
Completed
1,242
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Japan Community Health care Organization Kyushu Hospital" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Bayer" with 3 trials
sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Chugai Pharmaceutical" with 2 trials sponsored and "Arena Pharmaceuticals"
with 2 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Japan Community Health care Organization Kyushu Hospital"
#1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Zai Lab (Shanghai) Co., Ltd." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Japan Community Health care Organization Kyushu Hospital
According to Clinical.Site data, the most researched conditions in "Japan Community Health care Organization Kyushu Hospital" are
"Heart Failure" (3 trials), "Ulcerative Colitis" (2 trials), "Anemia" (1 trials), "Arthroplasty, Replacement, Knee" (1 trials) and "Extensive Disease Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Japan Community Health care Organization Kyushu Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Japan Community Health care Organization Kyushu Hospital
Most popular intervention types in "Japan Community Health care Organization Kyushu Hospital" are "Drug" (13 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Empagliflozin" (3 trials), "Etrasimod" (2 trials), "ASA 100 mg" (1 trials) and "Bemarituzumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Japan Community Health care Organization Kyushu Hospital
The vast majority of trials in "Japan Community Health care Organization Kyushu Hospital" are
16 trials for "All" genders.
Clinical Trials Status at Japan Community Health care Organization Kyushu Hospital
Currently, there are NaN active trials in "Japan Community Health care Organization Kyushu Hospital".
undefined are not yet recruiting,
4 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Japan Community Health care Organization Kyushu Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Japan Community Health care Organization Kyushu Hospital, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".